Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IncobotulinumtoxinA Dose Titration in Children with CP Spasticity
NCT05340439Phase 2Unknown
- Sponsor
- Università degli Studi di Verona
- Start
- Jun 2022
- Primary completion
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in spasticity, sponsored by Università degli Studi di Verona. Primary endpoint: Ashworth Scale. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT05340439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05340439.